Darwin Wealth Management’s Repligen RGEN Stock Holding History

Darwin Wealth Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100	Closed	-$9K	–	625
2020 Q1	$9K	Buy	+100	New	+$9.65K	﹤0.01%	496

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Darwin Wealth Management's RGEN Position: Q2 2020 in Review

Darwin Wealth Management sold out of Repligen (RGEN) in Q2 2020, closing a stake of 100 shares — an estimated $9K sold.

Darwin Wealth Management first reported a position in RGEN in Q1 2020 and held it in 1 quarter. The position peaked at $9K in Q1 2020. 370 funds tracked by Wall St. Rank hold RGEN as of Q2 2020.

Darwin Wealth Management reported no remaining Repligen position as of Q2 2020 after selling out during the quarter.
Darwin Wealth Management sold 100 Repligen shares in Q2 2020, an estimated $9K.
Darwin Wealth Management first reported a position in Repligen in Q1 2020 and held it in 1 quarter.
Darwin Wealth Management's Repligen position peaked at $9K in Q1 2020.
370 funds tracked by Wall St. Rank held Repligen as of Q2 2020.

Based on Darwin Wealth Management's 13F filing for Q2 2020, filed 6 Aug 2020.